Anne Wojcicki Overview

  • Investor Type
  • Angel

  • Status
  • Active

  • Professionals
  • 1

Professionals

  • Investments
  • 51

  • Portfolio
  • 42

  • Exits
  • 4

Exits

Anne Wojcicki General Information

Description

Ms. Anne Wojcicki is a Co-Founder and serves as Chief Executive Officer and Board Member at 23andMe. She also serves as President and Chairwoman at The Anne Wojcicki Foundation. Prior to founding the firm in 2006, she had a 10-year background in healthcare investing, focused primarily on biotechnology companies. She is also a General Partner at Covalence Life Sciences Partners. Prior to joining Covalence, she served as a Senior Research Analyst for the healthcare of Amerindo Investment Advisors. Prior to that, she was at Andor Capital Management as Healthcare Analyst, at Ardsley Partners as Healthcare Analyst, and at Investor AB as Senior Healthcare Analyst. She also worked at the National Institute of Health as a Research Associate in Oncology and Hematology. She also worked at the Weizmann Institute as a Research Associate in Biochemistry and at Yale University as a Research Associate in the Biochemistry Department. She holds a B.S. in Biology from Yale University in 1996.

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Corporate Office
  • San Francisco, CA
  • United States

Anne Wojcicki Investments (51)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Ezra (Diagnostic Equipment) 07-Feb-2024 Later Stage VC 0000 Diagnostic Equipment Generating Revenue
Orchid (Other Healthcare Technology Systems) 05-Dec-2023 00000 00000 0000 Other Healthcare Technology Systems Generating Revenue 0000 00000000
Dwellsy 01-Nov-2023 0000 00000 000.00 Real Estate Services (B2C) Generating Revenue 0000 00000000
Orchid (Other Healthcare Technology Systems) 01-Aug-2023 00000 00000 Other Healthcare Technology Systems Generating Revenue 0000 00000000
Eureka (Outcome Management (Healthcare)) 12-Jul-2023 0000 00000 000 Outcome Management (Healthcare) Startup 0000 00000000
CalypsoAI 27-Jun-2023 00000 00000 0000 Business/Productivity Software Generating Revenue 0000 00000000
Helium Health 05-Jun-2023 00000 00000 0000 Medical Records Systems Generating Revenue 0000 00000000
Nest Genomics 31-Mar-2023 0000 00000 00.00 Other Healthcare Technology Systems Generating Revenue 0000 00000000
Samaya 01-Mar-2023 Early Stage VC Business/Productivity Software Generating Revenue 0000 00000000
Wisdo Health 05-Jan-2023 Early Stage VC 000 Social/Platform Software Generating Revenue 0000 00000000

Anne Wojcicki Exits (4)

Company Name Exit Date Exit Type Exit Size
Twigtale 01-Mar-2023 Secondary Transaction - Private
SpoonfulONE 01-Jan-2022 000000000000000000
23andMe 10-Jun-2021 Reverse Merger 00000
Call9 09-Apr-2019 Out of Business

Anne Wojcicki Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Anne Wojcicki Team (1)

Name Title Deals Funds Boards Office
Anne Wojcicki Angel Investor 00 0 San Francisco, CA

Anne Wojcicki Co-Investors (451)

Name With Exits Lead Partner Series Industry
Susan Wojcicki 9 0 Series chart Industry bar
Gaingels 0 0 Series chart Industry bar
Lux Capital 0 0 Series chart Industry bar
Y Combinator 0 0 Series chart Industry bar
Khosla Ventures 0 0 Series chart Industry bar

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »